Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection
Year: 2003
Type: article
Abstract: Streptococcus pneumoniae cause considerable morbidity and mortality, with persistent neurological sequelae, particularly in young children and the elderly. It is widely assumed that carriage occurs through direct mucosal colonization from the environment whereas meningitis results from invasion from the blood. However, the results of published studies can be interpreted that pneumococci may enter the brain directly from the nasal cavity by axonal transport through olfactory nerves. This hypothesis is based on findings that (i) teichoic acid of the pneumococcal cell wall interact with gangliosides (GLS), (ii) the interaction of GLS with cholera toxin leads to axonal transport through the olfactory nerves into the brain, and (iii) viruses enter the brain through axonal transport into olfactory nerves. After nasal inoculation, we observe high numbers of pneumococci in nasal washes and the olfactory nerves and epithelium. Significant numbers of pneumococci also infected the olfactory bulbs, brain, and the trigeminal ganglia. The absence of bacteremia in this model makes it unlikely that the bacteria entered the brain from the blood stream. Recovery of colony-forming units from the brain, lungs, olfactory nerves, and epithelium and nasal washes was inhibited by incubating pneumococci with GLS before nasal inoculation. These findings, confirmed by PCR and immunohistochemistry, support a GLS-mediated process of infection and are consistent with pneumococci reaching the brain through retrograde axonal transport.
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: Alternative approaches for NALT-based immunity to respiratory pathogens, G1459293849, G1540835335, CELLULAR AND MOLECULAR MECHANISMS FOR MUCOSAL IMMUNITY, ENTERIC PATHOGENS - MUCOSAL RESEARCH UNIT, G5408489098, PspA: A Potential Pneumococcal Vaccine Component, CYSTIC FIBROSIS GENE THERAPY CORE CENTER, PspA mechanisms of humoral immunity, functional assays, and optimal vaccine const, Ab5 Toxins Nasal Adjuvant Target the Olfactory Bulbs/CNS
OpenAlex ID: W2148525358
